Aspen Aerogels, Inc. (NYSE:ASPN) Receives Average Recommendation of "Moderate Buy" from Analysts

Key Points

• Aspen Aerogels, Inc. (NYSE:ASPN) has received a consensus rating of "Moderate Buy" from analysts, with an average target price of $19.50.
• The company reported earnings of ($0.04) per share for the last quarter, exceeding analysts' expectations, and had a revenue of $78.02 million, which was above estimates.
• Recent institutional investments have led to a significant increase in holdings, with Nisa Investment Advisors LLC raising its stake by 1,094.8% in the second quarter.

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) have been assigned an average rating of "Moderate Buy" from the ten research firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $19.50.

A number of brokerages have issued reports on ASPN. Canaccord Genuity Group decreased their price target on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a report on Friday, August 8th. Barclays lowered shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and lifted their target price for the company from $7.00 to $16.00 in a report on Monday, August 11th.

Aspen Aerogels Trading Up 3.2%

NYSE ASPN opened at $7.09 on Friday. Aspen Aerogels has a 1 year low of $4.16 and a 1 year high of $30.24. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. The company has a market capitalization of $583.93 million, a PE ratio of -1.86 and a beta of 2.65. The company has a fifty day moving average of $7.16 and a 200 day moving average of $6.44.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.08. The business had revenue of $78.02 million during the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The company's revenue was down 33.8% on a year-over-year basis. During the same quarter last year, the business posted $0.21 EPS. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. Research analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current year.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the firm's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the sale, the chief accounting officer directly owned 19,879 shares of the company's stock, valued at approximately $145,315.49. This trade represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 4.30% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Nisa Investment Advisors LLC increased its holdings in Aspen Aerogels by 1,094.8% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company's stock worth $28,000 after acquiring an additional 4,390 shares in the last quarter. SBI Securities Co. Ltd. grew its position in shares of Aspen Aerogels by 67.3% in the second quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company's stock valued at $38,000 after purchasing an additional 2,551 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of Aspen Aerogels by 184.6% during the second quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company's stock worth $43,000 after purchasing an additional 4,693 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of Aspen Aerogels during the 1st quarter worth about $43,000. Finally, Banque Cantonale Vaudoise acquired a new position in shares of Aspen Aerogels during the 1st quarter worth about $45,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.